Zusammenfassung
□ Hintergrund
Seit Anfang der 80er Jahre haben systematische Untersuchungen unsere Kenntnisse über das Krankheitsbild der spontanen bakteriellen Peritonitis stark erweitert. Bedeutsame Einsichten in Epidemiologie, Pathogenese, klinische Symptomatik, Diagnostik und Therapie dieser Erkrankung, die eine häufige Komplikation bei Patienten mit Leberzirrhose und Aszites darstellt, konnten gewonnen werden. Aktuelle Forschungen befassen sich in erster Linie mit Fragen der Therapie und der Prophylaxe.
□ Ziel
Ziel dieser Übersicht ist eine umfassende Darstellung der verschiedenen Aspekte dieser Erkrankung auf der Basis der vorliegenden Literatur.
□ Schlußfolgerungen
Da einerseits die klinische Symptomatik sehr blande sein kann, andererseits aber die Prognose sehr schlecht ist, ist es äußerst wichtig, dieses Krankheitsbild in die differentialdiagnostischen Überlegungen einzubeziehen, um frühzeitig die Diagnose zu stellen und eine adäquate Therapie einzuleiten.
Abstract
□ Background
Since the beginning of the eighties systematic investigations broadened our knowledge about the clinical picture of spontaneous bacterial peritonitis very much. Important insights into epidemiology, pathogenesis, symptomatology, diagnosis and therapy of this disease, which is a frequent complication in patients with cirrhosis of the liver and ascites, could be gained. Actual research work primarily deals with questions of therapy and prophylaxis.
□ Aim
Aim of this review is a comprehensive presentation of the different aspects of this disease on the basis of the present literature.
□ Conclusions
As on the one side the clinical symptoms may be very little and on the other side the prognosis is very bad, it is extremely important to take this entity into the differential considerations to make an early diagnosis and to start an adequate therapy early.
Literatur
Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990;98:127–33.
Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993;104:1133–8.
Ariza J, Gudiol F, Dolz C, et al. Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatology 1986;6:906–10.
Ariza J, Xiol X, Esteve M, et al. Aztreonam vs. cefotaxime in the treatment of gramnegative spontaneous peritonitis in cirrhotic patients. Hepatology 1991;14:91–8.
Bac DJ, Siersema PD, Mulder PGH, et al. Spontaneous bacterial peritonitis: outcome and predictive factors. Eur J Gastroenterol Hepatol 1993;5:635–40.
Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention. Am J Med 1994;97:169–75.
Bode JC, Bode C, Heidelbach R, et al. Jejunal microflora in patients with chronic alcohol abuse. Hepato-Gastroenterology 1984;31:30–4.
Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353–8.
Carey WD, Boayke A, Leatherman J. Spontaneous bacterial peritonitis: clinical and laboratory features with reference to hospital-acquired cases. Am J Gastroenterol 1986;81:1156–6.
Conn HO. Spontaneous peritonitis and bacteremia in Laennec’s cirrhosis caused by enteric organism. Ann Intern Med 1964;60:568.
Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis. Medicine (Baltimore) 1971;50:161–93.
Cormican MG, Runyon BA, Jones RN. In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis. J Chemother 1995;7: 197–200.
Crossley IR, Williams R. Spontaneous bacterial peritonitis. Gut 1985;26:325–31.
Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985;5:457–62.
Fong TL, Akriviadis EA, Runyon BA, et al. Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis. Hepatology 1989;9:423–6.
Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 1992;21:257–75.
Gilbert JA, Kamath PS. Spontaneous bacterial peritonitis: an update. Mayo Clin Proc 1995;70:365–70.
Gines P. Spontaneous bacterial peritonitis. Curr Opin Gastroenterol 1992;8:403–8.
Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12:716–24.
Grange JD, Amiot X, Grange V, et al. Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology 1990;11:360–4.
Gross V, Andus T, Leser HG, et al. Spontaneous bacterial peritonitis. In: Holstege A, Schölmerich J, Hahn EG. Portal hypertension (Falk Symposium 79). Dordrecht-Boston-London: Kluwer Academic Publishers, 1995:397–407.
Hallack A. Spontaneous bacterial peritonitis. Am J Gastroenterol 1989;84:345–50.
Ho H, Zuckerman MJ, Guerra LG, et al. The role of invasive procedures in the development of nosocomial bacterial peritonitis. Gastroenterology 1991;100:A752.
Ho H, Zuckerman MJ, Ho TK, et al. Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis. Am J Gastroenterol 1996;91:735–42.
Hoefs JC. Spontaneous bacterial peritonitis: prevention and therapy. Hepatology 1990;12:776–81.
Hoefs J, Canawati H, Sapico F, et al. Onset of spontaneous bacterial peritonitis relative to the time of admission. Hepatology 1980;1:A 1025.
Kaymakoglu S, Eraksoy H, Ökten A, et al. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy. Eur J Gastroenterol Hepatol 1997;9:71–6.
Kubba AK, Young M. Ludwig van Beethoven: a medical biography. Lancet 1996;347:167–70.
Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16:724–7.
Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol 1997;26:88–95.
Martini GA, Phear EA, Ruebner B, et al. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity. Clin Sci 1957;16:35–51.
Mercader J, Gomez J, Ruiz J, et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy 1989;35:Suppl 2:23–6.
Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996;111:1011–7.
Novella M, Sola R, Soriano G, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997;25:532–6.
Pariente EA. Antibiotic treatment of spontaneous bacterial peritonitis: don’t forget enterococci! (letter) Gastroenterology 1992;102:375–6.
Pelletier G, Salmon D, Ink O, et al. Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J Hepatol 1990;10:327–31.
Pelletier G, Lesur G, Ink O, et al. Asymptomatic bacterascites: is it spontaneous bacterial peritonitis? Hepatology 1991;14:112–5.
Press AG, Meyer zum Büschenfelde KH, Ramadori G. Die spontane bakterielle Peritonitis. Z Gastroenterol 1992;30:543–52.
Propst T, Propst A, Schauer G, et al. Spontane bakterielle Peritonitis bei chronischer Lebererkrankung mit Aszites. Dtsch Med Wochenschr 1993;118:943–6.
Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985;5:463–7.
Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995;21:674–9.
Rolachon A, Cordier L, Bacq Y, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995;22:1171–4.
Rolando N, Gimson A, Philpott-Howard J, et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 18;1993:290–4.
Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 1984;4:447–50.
Runyon, BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984;4:1209–11.
Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med 1986;146:2259–61.
Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986;91:1343–6.
Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988;8:632–5.
Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351–5.
Runyon BA, Antillon MR, Montano AA. Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement. Gastroenterology 1989;97:158–62.
Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 1990;12:710–5.
Runyon BA, Antillon MR. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascites fluid infection. Hepatology 1991;13:929–35.
Runyon BA, McHutchison JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 100 patients. Gastroenterology 1991;100:1737–42.
Runyon BA, Antillon MR, McHutchison JG. Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis. J Hepatol 1992;14:249–52.
Runyon BA. Bacterial infections in patients with cirrhosis. In: Holstege A, Schölmerich J, Hahn EG. Portal hypertension (Falk Symposium 79). Dordrecht-Boston-London: Kluwer Academic Publishers, 1995: 167–72.
Sader HS, Runyon BA, Erwin ME, et al. Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis. Diagn Microbiol Infect Dis 1995;21:105–10.
Salmeron JM, Tito L, Rimola A, et al. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. J Hepatol 1992;14:280–5.
Sauter G, Ruckdeschel G, Sauerbruch T. Antibiotische Prophylaxe und Therapie infektiöser Komplikationen. Z Gastroenterol 1992;30:705–8.
Savli H, Pristautz H, Zach G, et al. Spontaneous bacterial peritonitis: a serious problem in patients with ascites. Eur J Gastroenterol Hepatol 1991;4:165–71.
Schembre D, Bjorkman DJ. Post-sclerotherapy bacterial peritonitis. Am J Gastroenterol 1991;86:481–6.
Schölmerich J, Gerbes AL, Andus T, et al. Spontane bakterielle Peritonitis bei Leberzirrhose mit Aszites. Dtsch Med Wochenschr 1995;120:454–61.
Selby WS, Norton ID, Pokorny CS, et al. Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endoscopy 1994;40:680–4.
Singh N, Gayowski T, Yu VL, et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995;122:595–8.
Sola R, Andreu M, Coll S, et al. Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study. Hepatology 1995;21:340–4.
Soriano G, Guarner C, Teixido M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991;100:477–81.
Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267–72.
Stassen WN, McCullongh AJ, Hilton PK. Spontaneous bacterial peritonitis caused by Neisseria gonorrhoeae: evidence for a transfallopian route of infection. Gastroenterology 1985;88:804–7.
Tam F, Chow H, Cornish D, et al. The association of spontaneous bacterial peritonitis and sclerotherapy: a preliminary report. Gastroenterology 1988;94:A454.
Terg R, Levi D, Lopez P, et al. Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci 1992;37:1499–504.
Tito L, Rimola A, Gines P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988;8:27–31.
Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251–7.
Ukah FO, Merhav H, Kramer D, et al. Early outcome of liver transplantation in patients with a history of spontaneous bacterial peritonitis. Transplant Proc 1993,25:1113–5.
Wilcox CM, Dismukes WE. Spontaneous bacterial peritonitis: a review of pathogenesis, diagnosis, and treatment. Medicine (Baltimore) 1987;66:447–56.
Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996;23:719–23.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zundler, J., Bode, J.C. Die spontane bakterielle Peritonitis. Med Klin 93, 612–618 (1998). https://doi.org/10.1007/BF03042676
Issue Date:
DOI: https://doi.org/10.1007/BF03042676